These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9701102)

  • 1. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation.
    Eckman MH; Falk RH; Pauker SG
    Arch Intern Med; 1998 Aug 10-24; 158(15):1669-77. PubMed ID: 9701102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
    Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD
    Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation.
    Seto TB; Taira DA; Tsevat J; Manning WJ
    J Am Coll Cardiol; 1997 Jan; 29(1):122-30. PubMed ID: 8996304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for atrial fibrillation. The value of decision analysis.
    Greenberg ML; Malenka DJ; Disch DL
    Cardiol Clin; 1996 Nov; 14(4):623-40. PubMed ID: 8950062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
    Gage BF; Cardinalli AB; Albers GW; Owens DK
    JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation.
    Lee VW; Tsai RB; Chow IH; Yan BP; Kaya MG; Park JW; Lam YY
    BMC Cardiovasc Disord; 2016 Aug; 16(1):167. PubMed ID: 27581874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
    O'Brien CL; Gage BF
    JAMA; 2005 Feb; 293(6):699-706. PubMed ID: 15701911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone.
    Disch DL; Greenberg ML; Holzberger PT; Malenka DJ; Birkmeyer JD
    Ann Intern Med; 1994 Mar; 120(6):449-57. PubMed ID: 8311367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
    Eckman MH; Rosand J; Greenberg SM; Gage BF
    Ann Intern Med; 2009 Jan; 150(2):73-83. PubMed ID: 19153410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective.
    Ademi Z; Pasupathi K; Liew D
    Appl Health Econ Health Policy; 2017 Jun; 15(3):363-374. PubMed ID: 27699648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation.
    Lanitis T; Kongnakorn T; Jacobson L; De Geer A
    Thromb Res; 2014 Aug; 134(2):278-87. PubMed ID: 24935675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
    Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
    Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation.
    de Paola AA; Figueiredo E; Sesso R; Veloso HH; Nascimento LO;
    Int J Cardiol; 2003 Apr; 88(2-3):157-66. PubMed ID: 12714194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
    Eckman MH; Rosand J; Knudsen KA; Singer DE; Greenberg SM
    Stroke; 2003 Jul; 34(7):1710-6. PubMed ID: 12805495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.